🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis

Recruitingn/aAges 18 Years - 90 YearsAllUniversity of Ulm
NCT03044223 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The present study focuses on patients with Pseudomonas aeruginosa (PSA) sepsis. The aim of the present study is to find out whether the M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotype predominates in blood monocytes in critically ill patients with PSA-sepsis, and whether the severity of sepsis and outcome is associated with distinct monocyte phenotype and function.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * age \> 18 years * critically ill patients with sepsis * microbiologically proven infection with Pseudomonas aeruginosa Exclusion Criteria: * life expectancy \< 24 hours * participation in other studies
💊

What it tests

  • Not listed
📍

Where

1 site
Clinic of Anesthesiology
Ulm, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy